A study using a series of LGI1 and ADAM22 hypomorphic mice revealed that ~50 % of LGI1 and ~10 % of ADAM22 protein levels are sufficient to prevent lethal epilepsy (Seagar et al., 2017; Yokoi et al., 2021). Here, ADAM22 is linked to epilepsy.